Lv1
30 积分 2025-07-05 加入
Real-World Evidence on Ibrutinib in First-Line Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma: A Comprehensive Review
1个月前
已完结
Continuous or Fixed-Duration Maintenance Therapy in Multiple Myeloma
1个月前
已完结
Clinical Feature and Predictive Model for Transplanted Patients with Functional High-Risk Multiple Myeloma
2个月前
已完结
TRAIL-induced eradication of primary tumour cells from multiple myeloma patient bone marrows is not related to TRAIL receptor expression or prior chemotherapy
2个月前
已完结
TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells
2个月前
已完结
Aponermin: First Approval
5个月前
已完结
Prospective real-world evaluation of t(11;14) prevalence and disease biology in multiple myeloma: MEDICI study analysis
7个月前
已完结
Haploinsufficiency of Lipin3 leads to hypertriglyceridemia and obesity by disrupting the expression and nucleocytoplasmic localization of Lipin1
7个月前
已完结
Efficacy and safety of aponermin combined with immunomodulators in relapsed/refractory multiple myeloma
8个月前
已关闭
Zanubrutinib plus Ixazomib and Dexamethasone in Newly Diagnosed Symptomatic Waldenström Macroglobulinemia: A Phase II Study
8个月前
已完结
皖公网安备34019202002308
